Definitive Contract 75F40120C00021
Award Date
3/6/20
Potential Completion Date
9/9/23
Potential Value
$973K
Federal Agency
Food and Drug Administration
Awardee
University Of Connecticut
Ultimate Awardee
Secretary Of State Connecticut
NAICS Category
611310 - Colleges, Universities, and Professional Schools
PSC Category
AN16 - R&D- Medical: Biomedical (Management/Support)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Storrs, CT 06269, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
11
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Connecticut (UConn) has been awarded a $1,103,886 firm-fixed-price definitive federal contract by the Food and Drug Administration (FDA) for research and development related to the impact of active pharmaceutical ingredients on in situ forming implants and understanding in vitro and in vivo performance differences. This contract, which has a completion date of September 29, 2026, was issued under the FDA's Broad Agency Announcement for research and development to support...
This is a $219,991 cost-no-fee definitive contract awarded by the Food and Drug Administration (FDA) to the University of Connecticut (UConn) to conduct research on the "Continuous Manufacturing of Liposomes: Materials Understanding and Process Control." The contract is part of the FDA's broader program on continuous manufacturing of liposomes, a type of drug delivery system. UConn, a leading public research institution, will leverage its expertise in materials science, engineering,...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of Connecticut for "Assessing Long-Acting Injectable Formulations Using In Vivo Imaging". The potential value of the contract is $1,131,742.00 and it has a completion date of September 29, 2024. The contract is not set aside for a specific business category. Under this contract, the University of Connecticut is conducting research and analysis on...
The University of Connecticut has been awarded a definitive contract by the Department of Health and Human Services Food and Drug Administration to continue processing liposomal nanoparticles as reference materials for drug product development. With a potential value of $349,364, this time and materials contract does not have a set-aside designation and is to be completed by May 31, 2023. As the prime contractor, the University will utilize its expertise in nanotechnology and materials...
This federal contract award, with ID 75F40119C10152, was issued by the Food and Drug Administration (FDA) to the University of Connecticut (UConn) for a project titled "The Feasibility and Effectiveness of an Opioid Package Prototype (OPP) to Impact Opioid Prescribing, Dispensing, and Patient Use Outcome." The $831,029.30 definitive contract has a completion date of April 4, 2025 and is a cost-type contract with no fee. The project aims to study the impact of various opioid packaging...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to the University of Connecticut (UConn) for a comparative trial of different packaging components of an opioid packaging solution. The study aims to evaluate the effectiveness of different opioid package designs, patient education messages, and calendar components on prescribing, dispensing, and patient use of oxycodone. The contract, which has a ceiling value of $1,417,987.00, does not have a set-aside designation....
The University of Connecticut (UConn) was awarded a $1,310,263 cost-no-fee definitive contract by the Food and Drug Administration (FDA) to enhance and validate in vitro-in vivo correlation (IVIVC) methods for long-acting injectable drug products to accelerate their generic development. The contract is part of the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various areas to modernize regulatory science and support...
This firm fixed price purchase order contract, valued at $22,610.38, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to the University of Connecticut (UConn) to develop resources for designing age-friendly workplaces in manufacturing support. UConn, a non-profit 1862 land-grant educational institution, will leverage its multidisciplinary expertise to support this federal priority. The contract has no set-aside designation. UConn has a broad portfolio of federal...
This federal contract award to the University of Connecticut (UConn) is for the NIH Pain Consortium Centers of Excellence in Pain Education program. The base contract was awarded on September 18, 2015 with a period of performance through September 17, 2016 and a ceiling value of $913,933.75. The contract is a definitive cost-no-fee contract issued by the National Institute on Drug Abuse, a civilian agency under the Department of Health and Human Services. This award does not utilize any...
This is a definitive contract awarded by the Defense Health Agency to the University of Connecticut (UConn) on September 21, 2015. The contract has a ceiling value of $2,248,917.00 and an ultimate completion date of September 22, 2020. It is not set aside under any special designation. The contract involves UConn conducting research and development work focused on miniaturizing sensor signal processing units, optimizing potentiostats, and testing new sensor iterations in vivo. UConn has...